News and Trends 3 Mar 2023
Debiopharm adds to oncology pipeline
Debiopharm, an independent Swiss-based, biopharmaceutical company, has obtained the global rights for FT-3171, a small molecule USP1 inhibitor program targeting…
Novo Nordisk
- Latest Posts
News and Trends 10 Feb 2023
Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study
Heartseed Inc. and Novo Nordisk A/S say Heartseed has successfully dosed the first patient in a phase 1/2 clinical study…
News and Trends 17 Jan 2023
Is Copenhagen the world capital of life science?
Denmark’s leading life science companies, public foundations, municipalities, universities and hospitals will work together to position Copenhagen as the world…
News and Trends 7 Dec 2022
FDA clears insulin pen medical device
BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, has received 510(K) clearance from…
ADVERTISEMENT
More News! 23 Nov 2022
Novo Nordisk announces $750M facility expansion
Novo Nordisk has announced plans to invest DKK 5.4 bn ($750m) in the expansion of existing facilities in Bagsværd, Denmark. …
More News! 10 Nov 2022
Novo Nordisk supports Plant2Food platform with €27M funding
Novo Nordisk Foundation will support new open collaborative platform, Plant2Food, to accelerate the development of plant-based foods with up to…
News and Trends 4 Oct 2022
ASPIRE set up to collaborate on amyloidosis
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research Consortium (ARC). ASPIRE (amyloidosis stakeholder…
News and Trends 21 Sep 2022
Novo Nordisk Foundation investing $200M for first quantum computer for life sciences research
The Novo Nordisk Foundation has awarded a grant of $200 million to establish the first full-scale quantum computer for the…
News and Trends 6 Sep 2022
More companies enter BioInnovation Institute Venture Lab program
Nine ventures and two projects have become the latest addition to The BioInnovation Institute’s (BII) Venture Lab acceleration program for…
News and Trends 6 Jun 2022
Report shows growth of life sciences sector in eastern Denmark
A new report on the Danish contribution to the Medicon Valley has been published. The report, Life Science in Eastern…
ADVERTISEMENT
News and Trends 17 Jan 2022
Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments
The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant Novo Nordisk to search for…
In Depth 15 Nov 2021
The Future of Diabetes Treatment: Is a Cure Possible?
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science is striving to find a…
News and Trends 1 Oct 2021
Novo Nordisk Foundation Pumps €85M into Carbon Capture Research
As pressure mounts to tackle climate change, the Danish Novo Nordisk Foundation has granted €84.7M to the world's first research…
News and Trends 8 Jun 2021
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent approval of AstraZeneca’s Farxiga alongside…
News and Trends 15 Jun 2020
Novo Nordisk Foundation Commits €100M Grant to Developing Green Tech
The Novo Nordisk Foundation has awarded a five-year grant of €100M to the DTU Biosustain research center near Copenhagen to…
News and Trends 13 May 2020
Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon
Patients with the chronic liver disease NASH must now wait even longer for an approved treatment, after French biotech Genfit’s…
ADVERTISEMENT
In Depth 3 Mar 2020
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them…
More News! 9 Oct 2019
Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation…
News and Trends 23 Sep 2019
FDA Greenlights First Oral Version of Novo Nordisk’s Type 2 Diabetes Drug
The first oral drug for type 2 diabetes belonging to the class of GLP-1 agonists, developed by Novo Nordisk, has…
News and Trends 17 Dec 2018
Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease
Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to remove excess fatty molecules called…